Episode 032: Harsh Thakkar (@harshvthakkar) interviews Elizabeth Smalley (@elizabeth-smalley-product-leader), the Director of Product Management, Data and Analytics at Aris Global. 

Elizabeth discusses proactive safety signal detection in the context of drug development and the challenges faced in this space. She highlights the importance of utilizing real-world data and changing the methods of detection to overcome these challenges, along with limitations in reporting adverse events and the potential of AI in drug repurposing.

Harsh and Elizabeth touch on ethical considerations in AI and the potential for AI to be used in various emerging sectors of life sciences. They provide tips on staying up-to-date with the latest developments in the field and offer advice for working in life sciences. They emphasize the need for democratizing data and AI to make it accessible to all users.

-----
Links:

*Elizabeth's LinkedIn
*Aris Global LinkedIn
*Aris Global
*Would you rather watch the video episode? Subscribe to full-length videos on our YouTube channel.

-----
Show Notes:

(7:30) Using AI to analyze EMR data for pharmaceutical insights. 

(11:43) AI in life sciences and healthcare.

(18:15) Ethical Considerations in AI and transparency.

(22:47) Learning Resources and Staying Up-to-Date. 

(25:59) The Impact and Challenges of Working in Life Sciences.

For transcripts, check out the podcast website - www.lifesciencespod.com